E. Collatz
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.5%
Papers in
-
- Antibiotic Resistance in Bacteria 46
-
- RNA and protein synthesis mechanisms 16
- RNA modifications and cancer 9
- Co-authors
- Isabelle Podglajen (16 shared papers)Ludwig Gutmann (22 shared papers)J. Breuil (10 shared papers)Patrice Courvalin (8 shared papers)I Casin (10 shared papers)Ira G. Wool (7 shared papers)F. W. Goldstein (9 shared papers)J. F. Acar (9 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (20 papers)Journal of Bacteriology (8 papers)Journal of Biological Chemistry (7 papers)Molecular Microbiology (4 papers)The Journal of Infectious Diseases (3 papers)
- Partner nations
- FranceUnited StatesAustria
In The Last Decade
E. Collatz
82 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 96
- Molecular Medicine 1.8k
- Endocrinology 661
- Applied Microbiology and Biotechnology 175
- Clinical Biochemistry 457
- Infectious Diseases 706
Countries citing papers authored by E. Collatz
This map shows the geographic impact of E. Collatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Collatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Collatz more than expected).
Fields of papers citing papers by E. Collatz
This network shows the impact of papers produced by E. Collatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Collatz. The network helps show where E. Collatz may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Collatz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 289 | |
| 2 | 1985 | 164 | |
| 3 | 1994 | 158 | |
| 4 | 1994 | 121 | |
| 5 | 1991 | 106 | |
| 6 | 1980 | 106 | |
| 7 | 1978 | 103 | |
| 8 | 1989 | 100 | |
| 9 | 1995 | 96 | |
| 10 | 1988 | 94 | |
| 11 | 1998 | 90 | |
| 12 | 1987 | 76 | |
| 13 | 1990 | 74 | |
| 14 | 1993 | 73 | |
| 15 | 1999 | 71 | |
| 16 | 1976 | 69 | |
| 17 | 1996 | 63 | |
| 18 | 1976 | 63 | |
| 19 | 1992 | 62 | |
| 20 | 1983 | 62 |
About E. Collatz
E. Collatz is a scholar working on Molecular Medicine, Molecular Biology, Pharmacology, Genetics and Infectious Diseases, having authored 82 papers that have together received 3.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (46 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers), RNA and protein synthesis mechanisms (16 papers), Bacterial Genetics and Biotechnology (15 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Bacterial Identification and Susceptibility Testing (9 papers), RNA modifications and cancer (9 papers) and Salmonella and Campylobacter epidemiology (7 papers). The work is most often cited by research in Molecular Medicine (1.8k citations), Endocrinology (661 citations), Applied Microbiology and Biotechnology (175 citations), Clinical Biochemistry (457 citations) and Infectious Diseases (706 citations). E. Collatz has collaborated with scholars based in France, United States and Austria. Frequent co-authors include Isabelle Podglajen, Ludwig Gutmann, J. Breuil, Patrice Courvalin, I Casin, Ira G. Wool, F. W. Goldstein, J. F. Acar, Guy Tran Van Nhieu and D Billot-Klein. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Bacteriology, Journal of Biological Chemistry, Molecular Microbiology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.